ASP Isotopes, a precommercial advanced materials company headquartered in Washington, D.C., focuses on enriching natural isotopes for healthcare and technology industries using proprietary Aerodynamic Separation Process technology. The firm went public on November 10, 2022, and employs 76 people.
ASPI has been in the news recently: ASP Isotopes Inc. (NASDAQ: ASPI) is facing a class action lawsuit for allegedly misleading investors about its nuclear technologies, which resulted in a significant stock drop of over 23% in late November 2024. Investors are required to file a lead plaintiff motion by February 3, 2025, in response to these allegations.
📡️ Materials
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
